| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |